Share-based Payment Arrangement, Expense of AGILE THERAPEUTICS INC from 31 Dec 2012 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
AGILE THERAPEUTICS INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2012 to 30 Jun 2024.
  • AGILE THERAPEUTICS INC Share-based Payment Arrangement, Expense for the quarter ending 30 Jun 2024 was $284,000, a 41% decline year-over-year.
  • AGILE THERAPEUTICS INC annual Share-based Payment Arrangement, Expense for 2014 was $1,380,713, a 3.2% increase from 2013.
  • AGILE THERAPEUTICS INC annual Share-based Payment Arrangement, Expense for 2013 was $1,337,857, a 101% increase from 2012.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

AGILE THERAPEUTICS INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $284,000 -$198,000 -41% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $333,000 -$165,000 -33% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q2 2023 $482,000 -$187,000 -28% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q2
Q1 2023 $498,000 -$266,000 -35% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q3 2022 $536,000 -$351,000 -40% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $669,000 -$174,000 -21% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $764,000 +$22,000 +3% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q3 2021 $887,000 +$240,000 +37% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022 2022 Q3
Q2 2021 $843,000 +$4,000 +0.48% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $742,000 +$121,000 +19% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q3 2020 $647,000 +$269,000 +71% 01 Jul 2020 30 Sep 2020 10-Q/A 30 Dec 2021 2021 Q3
Q2 2020 $839,000 +$360,000 +75% 01 Apr 2020 30 Jun 2020 10-Q 26 Jul 2021 2021 Q2
Q1 2020 $621,000 +$131,000 +27% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021 2021 Q1
Q3 2019 $378,000 -$343,000 -48% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 $479,000 -$508,000 -51% 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020 2020 Q2
Q1 2019 $490,000 -$629,000 -56% 01 Jan 2019 31 Mar 2019 10-Q 05 May 2020 2020 Q1
Q3 2018 $721,000 -$246,000 -25% 01 Jul 2018 30 Sep 2018 10-Q 28 Oct 2019 2019 Q3
Q2 2018 $987,000 +$62,000 +6.7% 01 Apr 2018 30 Jun 2018 10-Q 01 Aug 2019 2019 Q2
Q1 2018 $1,119,000 +$284,000 +34% 01 Jan 2018 31 Mar 2018 10-Q 03 May 2019 2019 Q1
Q3 2017 $967,000 +$27,000 +2.9% 01 Jul 2017 30 Sep 2017 10-Q 02 Nov 2018 2018 Q3
Q2 2017 $925,000 -$30,000 -3.1% 01 Apr 2017 30 Jun 2017 10-Q 03 Aug 2018 2018 Q2
Q1 2017 $835,000 +$124,000 +17% 01 Jan 2017 31 Mar 2017 10-Q 07 May 2018 2018 Q1
Q3 2016 $940,000 +$194,000 +26% 01 Jul 2016 30 Sep 2016 10-Q 06 Nov 2017 2017 Q3
Q2 2016 $955,000 +$217,000 +29% 01 Apr 2016 30 Jun 2016 10-Q 28 Jul 2017 2017 Q2
Q1 2016 $711,000 01 Jan 2016 31 Mar 2016 10-Q 08 May 2017 2017 Q1
Q3 2015 $746,000 01 Jul 2015 30 Sep 2015 10-Q 07 Nov 2016 2016 Q3
Q2 2015 $738,000 01 Apr 2015 30 Jun 2015 10-Q 08 Aug 2016 2016 Q2

AGILE THERAPEUTICS INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2014 $1,380,713 +$42,856 +3.2% 01 Jan 2014 31 Dec 2014 10-K 26 Mar 2015 2014 FY
2013 $1,337,857 +$672,403 +101% 01 Jan 2013 31 Dec 2013 10-K 26 Mar 2015 2014 FY
2012 $665,454 01 Jan 2012 31 Dec 2012 10-K 26 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.